U.S. Markets closed

Johnson & Johnson’s Medical Devices Business

Daniel Collins
Johnson & Johnson’s Medical Devices Business

Johnson & Johnson’s (JNJ) Medical Devices segment consists of diabetes care, interventional solutions, orthopedics, surgery, and vision care. This segment generated net revenues of $6.8 billion in the first quarter compared to $6.3 billion in the first quarter of 2017, reflecting ~7.5% YoY (year-over-year) growth.